Two new iridoid glycosides from Callicarpa nudiflora

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Cell Biology

Background:

• Callicarpa nudiflora is a plant species with potential medicinal properties.
• Iridoid glycosides are a class of natural compounds known for diverse biological activities.
• Hepatotoxicity, or liver damage, is a significant health concern requiring novel therapeutic strategies.

Purpose of the Study:

• To isolate and characterize new iridoid glycosides from Callicarpa nudiflora.
• To evaluate the hepatoprotective effects of the isolated compounds against d-galactosamine-induced liver toxicity.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation employing one- and two-dimensional Nuclear Magnetic Resonance (NMR) spectroscopy and mass spectrometry.
• In vitro bioassay using WB-F344 rat hepatic epithelial stem-like cells to assess toxicity.

Main Results:

• Two novel iridoid glycosides, designated callicoside E (1) and callicoside F (2), were successfully isolated.
• The chemical structures of compounds 1 and 2 were confirmed through comprehensive spectroscopic analysis.
• Both callicoside E and callicoside F demonstrated pronounced hepatoprotective activity, significantly reducing d-galactosamine-induced toxicity in the tested cell model.

Conclusions:

• Callicarpa nudiflora is a source of novel iridoid glycosides with potential therapeutic applications.
• Callicoside E and callicoside F exhibit significant hepatoprotective properties, warranting further investigation for drug development.
• These findings contribute to the understanding of natural products in mitigating liver damage.